BioHorizon Emerging Health Technology Database

Inside Emerging Health Technology is a concise, informative biweekly newsletter written by medical professionals that keeps our clients on the cutting edge of major developments in emerging health technology. Each issue of Inside Emerging Health Technology includes a brief summary of the developments and trends in emerging health technology over a two week period. We highlight the most compelling assessed technologies in concise reports and offer our recommendations for client action.

BioHorizon TechNotes™ provide timely insight and analysis of emerging technologies that will have major impacts on health services delivery. This critical information early in a health technology’s development and diffusion can be vital to senior management and program planners tasked with shaping health services now and in the future.

TechNotes profile emerging technologies, providing such essential details for decision making as: a description of the technology itself, up to date clinical trial date, the prevalence of the target disease, the technology’s regulatory status, the direct cost of the technology, demand/diffusion issues and other relevant details.

The universe of emerging health technologies is vast, and the rate at which change and innovation occurs is extraordinary. At BioHorizon, we make this fast-paced field manageable for our clients by distilling this information and presenting it in formats that can be taken in at a glance.

At the heart of our surveillance system is the BioHorizon emerging health technology database. This constantly growing, fully searchable database includes detailed information on over 520 companies and 2,430 technologies. Clients can easily search the database by target disease, technology classification, program area, regulatory status, BioHorizon Impact Score™, and more. Clients can study the history of a given emerging technology by viewing the complete record of postings and updates for each technology maintained in the database. The BioHorizon database is updated daily to ensure that the most recent information is included and made available to our clients.

Our team of medical professionals and researchers not only track and gather the most current emerging health technology news; we assess the anticipated impact of new technologies to assist our clients in making astute decisions. In order to assess emerging technologies with accuracy and objectivity, we have developed the BioHorizon Impact Score™ framework, an innovative analytical tool that allows us to evaluate and rank technologies according to anticipated impact, and offer recommendations to our clients. With this information, our clients can take the necessary steps to mitigate risk and take appropriate administrative actions in implementing emerging technologies in their health services programs.

The BioHorizon Impact Score™ for each assessed technology can be found in the BioHorizon searchable database. Scores are updated upon the release of new information, clinical trial results, FDA rulings and other critical developments. Our emerging health technology surveillance team assesses drugs, devices, and diagnostic tests using our proprietary BioHorizon assessment methodology. Each technology is assessed according to its efficacy in clinical trials, the incidence of the disease targeted, demand/diffusion parameters, and the degree to which it represents true medical innovation.